Rumen microbiome associates with postpartum ketosis development in dairy cows: a prospective nested casecontrol study
This difference raises concerns about safety and efficacy, making it vital for patients to approach compounded options with caution
For patients with cardiovascular risk factors, microdosing may offer a safer way to capture these health benefits without overwhelming the body with medication
Research discussed below shows tirzepatide can reduce markers of systemic inflammation including inflammatory cytokines through both weight reduction and direct metabolic effects
Proper medical oversight matters, particularly for patients with diabetes, kidney disease, history of pancreatitis, or other comorbidities
( 10.1161/CIRCULATIONAHA.112.091215) [DOI] [PubMed] [Google Scholar] Nyberg J, Anderson MF, Meister B, Alborn AM, Strom AK, Brederlau A, Illerskog AC, Nilsson O, Kieffer TJ, Hietala MA, et al